Annual Short Term Debt
$1.00 M
+$550.00 K+120.88%
December 31, 2023
Summary
- As of February 8, 2025, KROS annual short term debt is $1.00 million, with the most recent change of +$550.00 thousand (+120.88%) on December 31, 2023.
- During the last 3 years, KROS annual short term debt has risen by +$582.00 thousand (+137.59%).
- KROS annual short term debt is now at all-time high.
Performance
KROS Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$1.86 M
+$761.00 K+69.43%
September 30, 2024
Summary
- As of February 8, 2025, KROS quarterly short term debt is $1.86 million, with the most recent change of +$761.00 thousand (+69.43%) on September 30, 2024.
- Over the past year, KROS quarterly short term debt has increased by +$852.00 thousand (+84.78%).
- KROS quarterly short term debt is now at all-time high.
Performance
KROS Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
KROS Short Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +120.9% | +84.8% |
3 y3 years | +137.6% | +120.3% |
5 y5 years | +505.4% | - |
KROS Short Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +120.9% | at high | -100.0% |
5 y | 5-year | at high | +167.3% | at high | -100.0% |
alltime | all time | at high | +505.4% | at high | -100.0% |
Keros Therapeutics Short Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $1.86 M(+69.4%) |
Jun 2024 | - | $1.10 M(+4.4%) |
Mar 2024 | - | $1.05 M(+4.5%) |
Dec 2023 | $1.00 M(+120.9%) | $1.00 M(+64.5%) |
Sep 2023 | - | $611.00 K(>+9900.0%) |
Jun 2023 | - | $0.00(0.0%) |
Mar 2023 | - | $0.00(-100.0%) |
Dec 2022 | $455.00 K | $455.00 K(0.0%) |
Sep 2022 | - | $455.00 K(-32.1%) |
Jun 2022 | - | $670.00 K(-24.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $884.00 K(+2.6%) |
Dec 2021 | $862.00 K(+103.8%) | $862.00 K(+2.3%) |
Sep 2021 | - | $843.00 K(+87.8%) |
Jun 2021 | - | $449.00 K(+3.0%) |
Mar 2021 | - | $436.00 K(+3.1%) |
Dec 2020 | $423.00 K(+12.5%) | $423.00 K(+2.7%) |
Sep 2020 | - | $412.00 K(+3.0%) |
Jun 2020 | - | $400.00 K(+3.1%) |
Mar 2020 | - | $388.00 K(+3.2%) |
Dec 2019 | $376.00 K(+126.5%) | $376.00 K |
Dec 2018 | $166.00 K | - |
FAQ
- What is Keros Therapeutics annual short term debt?
- What is the all time high annual short term debt for Keros Therapeutics?
- What is Keros Therapeutics annual short term debt year-on-year change?
- What is Keros Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Keros Therapeutics?
- What is Keros Therapeutics quarterly short term debt year-on-year change?
What is Keros Therapeutics annual short term debt?
The current annual short term debt of KROS is $1.00 M
What is the all time high annual short term debt for Keros Therapeutics?
Keros Therapeutics all-time high annual short term debt is $1.00 M
What is Keros Therapeutics annual short term debt year-on-year change?
Over the past year, KROS annual short term debt has changed by +$550.00 K (+120.88%)
What is Keros Therapeutics quarterly short term debt?
The current quarterly short term debt of KROS is $1.86 M
What is the all time high quarterly short term debt for Keros Therapeutics?
Keros Therapeutics all-time high quarterly short term debt is $1.86 M
What is Keros Therapeutics quarterly short term debt year-on-year change?
Over the past year, KROS quarterly short term debt has changed by +$852.00 K (+84.78%)